Italy· 044888042
ALPROLIX*1 flacone EV 2.000 Unita' Internazionali + 1 siringa 5 ml + 1 stantuffo + 1 adattatore + 1 set infusione + 2 tamponi + 2 cerotti + 1 garza
A eftrenonacog alfa product containing eftrenonacog alfa, registered in Italy by SWEDISH ORPHAN BIOVITRUM AB(PU, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Eftrenonacog alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BD34 (eftrenonacog alfa), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Eftrenonacog alfa · ATC B02BD34
3 / 19 countries
- Franceprice
- Italyprice
- United Kingdom
The record
At a glance
- Active substance
- Eftrenonacog Alfa
- Manufacturer
- SWEDISH ORPHAN BIOVITRUM AB(PU
- Country
- Italy (IT)
- ATC code
- B02BD34
- ATC class
- Eftrenonacog alfa
- Defined daily dose
- 400 E, P
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic044888042ALPROLIX*1 flacone EV 2.000 Unita' Internazionali + 1 siringa 5 ml + 1 stantuffo + 1 adattatore + 1 set infusione + 2 tamponi + 2 cerotti + 1 garzaEUR 4555.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eftrenonacog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanエフトレノナコグ アルファ（遺伝子組換え）サノフィ
- SwitzerlandAlprolix
- CzechiaALPROLIXSwedish Orphan Biovitrum AB (publ), Stockholm
- SpainALPROLIX 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLESwedish Orphan Biovitrum Ab (Publ)
- FinlandALPROLIXSwedish Orphan Biovitrum AB (publ)
- FranceALPROLIX 1000 UI, poudre et solvant pour solution injectableSWEDISH ORPHAN BIOVITRUM (SUEDE)
- United KingdomAlprolix 1,000unit powder and solvent for solution for injection vialsSwedish Orphan Biovitrum Ltd
- IrelandALPROLIX 1000 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alprolix
- Liechtenstein · Alprolix
- Norway · Alprolix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dca2d085-bb71-474c-b6c0-c62a197d6fe9 GET /v1/drugs/dca2d085-bb71-474c-b6c0-c62a197d6fe9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4555.1,
"source": "aifa",
"currency": "EUR",
"strength": "EFTRENONACOG 2.000UI 1 UNITA' USO PARENTERALE",
"substance": "Eftrenonacog Alfa",
"equivalence_group": "JFI",
"transparency_flag": null
}See everything about eftrenonacog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.